secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001628280-25-059067
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Jack Kenny to board; Dr. Alison Hannah departs after 10 years
--------------------------------------------------------------------------------

- Dr. Alison Hannah resigns from NeoGenomics board effective Dec 31, 2025, after over 10 years of service.
- Jack Kenny appointed to board effective Jan 1, 2026; former CEO of Meridian Bioscience (taken private 2023).
- Mr. Kenny brings 30+ years of diagnostics and lab services experience; also serves on Orasure, DCN, Quantum-SI boards.
- Mr. Kenny's compensation is consistent with NeoGenomics' director compensation plan as disclosed in 2025 proxy.
- No related-party transactions involving Mr. Kenny requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/0001628280-25-059067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000162828025059067/neo-20251223.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-059067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer